RECRUITING

Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Nicotine enhances auditory-cognitive function because it mimics the brain's system for "paying attention" to important sounds amid distractions (for example, understanding speech in a noisy environment). In part, nicotine does this by activating inhibitory neurons in the auditory cortex. Since age-related hearing deficits result, in part, from the loss of inhibitory neurons in auditory cortex, this project will determine whether nicotine's effects can compensate for reduced inhibition in the aging auditory cortex and thereby restore auditory function. The investigators will use functional magnetic resonance imaging (fMRI) to measure the selectivity of responses in auditory cortex to tones of various frequencies. The investigators will measure the effects of nicotine (administered as chewing gum) and aging on these fMRI response properties. The investigators hypothesize that frequency selectivity will decrease with aging and increase following nicotine administration.

Official Title

Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex

Quick Facts

Study Start:2022-06-06
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05018117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * non-smokers with a score of 0-2 out of 10 maximum on the Fagerström index of smoking dependency
  1. * deafness or excessive hearing loss
  2. * smokers with a score between 3 and 10 on the Fagerström index of smoking dependency
  3. * history of psychiatric illness, neurological disorders, diabetes mellitus, renal failure, or cardiovascular disease
  4. * regular use of prescription medications (excluding oral contraceptives)
  5. * drug dependency

Contacts and Locations

Study Contact

Michael A Silver, PhD
CONTACT
5106423130
masilver@berkeley.edu

Principal Investigator

Michael A Silver, PhD
PRINCIPAL_INVESTIGATOR
University of California, Berkeley

Study Locations (Sites)

University of California, Berkeley
Berkeley, California, 94720
United States

Collaborators and Investigators

Sponsor: University of California, Berkeley

  • Michael A Silver, PhD, PRINCIPAL_INVESTIGATOR, University of California, Berkeley

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-06
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2022-06-06
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • nicotine
  • acetylcholine
  • functional magnetic resonance imaging

Additional Relevant MeSH Terms

  • Aging